Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Active, Not Recruiting

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

NCT06265220

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Artiva Investigational Site Birmingham Birmingham, Alabama, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site San Diego San Diego, California, United States
  • Artiva Investigational Site Aventura Aventura, Florida, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT05617677

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0012 Birmingham, Alabama, United States
  • Local Institution - 0229 Phoenix, Arizona, United States
  • Local Institution - 0193 Tucson, Arizona, United States
  • Kaiser Permanente Fontana, California, United States
View all 197 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

NCT05620407

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0063 La Jolla, California, United States
  • Local Institution - 0241 La Mesa, California, United States
  • Local Institution - 0242 San Diego, California, United States
  • Local Institution - 0143 San Leandro, California, United States
View all 180 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT06294236

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +33 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT06342960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Charite- Universitätsklinikum Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details
Active, Not Recruiting

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

NCT04179032

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Rosario, Argentina
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site Saint Augustin, Germany
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

NCT04582136

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Shenzhen People's Hospital Shenzhen, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Active, Not Recruiting

Centrally Acting ACE Inhibition in SLE

NCT04486118

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Northwell Rheumatology Great Neck, New York, United States
  • Andrew Shaw Manhasset, New York, United States
  • New York University School of Medicine New York, United States
View Trial Details
Active, Not Recruiting

A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

NCT05411016

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Cutaneous Lupus Erythematosus (CLE), +7 more
Locations
  • Fujita Health University Hospital Kutsukake, Aichi-ken, Japan
  • Japan Community Health care Organization Chukyo Hospital Minami, Aichi-ken, Japan
  • Juntendo University Urayasu Hospital Urayasu, Chiba, Japan
  • Kyusyu University Hospital Higashi, Fukuoka, Japan
View all 23 locations
View Trial Details

Related conditions